References
- E.H. Ostergaard, M.P. Magnussen, C.K. Nielsen, E. Eilertsen and H.H. Frey, Pharmacological properties of 3-n-butylamino-4-phenoxy-5-sulfarnylbenzoic acid (Bumetanide), a new potent diuretic, Arzneimiitelforschung, 22, 66-72 (1972)
- M.J. Asbury, P.B. Gatenby, S. OSullivan and E. Bourke, Bumetanide: potent new 'loop' diuretic, Br. Med. J., 1, 211-213 (1972) https://doi.org/10.1136/bmj.1.5794.211
- K.H. Olesen, B. Sigurd, E. Steiness and A. Leth, Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure, Acta. Med. Scand., 193, 119-131 (1973)
- D.L. Davies, A.F. Lant, N.R. Millard, A.J. Smith, J.W. Ward and G.M. Wilson, Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide, Clin. Pharmacal. Ther., 15,141-155 (1974) https://doi.org/10.1002/cpt1974152141
- E. Bourke, M.J.A. Asbury, S. O'Sullivan and P.B.B. Gatenby, The sites of action of bumetanide in man, Eur. J. Pharmacol., 23, 283-289 (1973) https://doi.org/10.1016/0014-2999(73)90096-4
- S.G. Kariander, R. Henning and O. Lundvall, Renal effects of bumetanide, a new saluretic agent, Eur. J. Clin. Pharmacol., 6, 220-223 (1973) https://doi.org/10.1007/BF00644735
- J.B. Puschett, Renal effects of bumetanide, J. Clin. Pharmacol., 21, 575-580 (1981) https://doi.org/10.1002/j.1552-4604.1981.tb05666.x
- G.K. McEvoy, O.H. Welsh Jr. and E.K. Snow, American Hospital Formulary Service, 41th eds., ASHP, Bethesda, U.S.A., pp. 2314-2319 (1999)
- D.E. Smith, High-performance liquid chromatographic assay for bumetanide in plasma and urine, J. Pharm. Sci., 71, 520-523 (1982) https://doi.org/10.1002/jps.2600710510
- H. Bokens, C. Bouscheidt and R.F. Muller, Determination of bumetanide in plasma by high-performance liquid chromatography, J. Chromatogr. B., 434, 327-329 (1988) https://doi.org/10.1016/0378-4347(88)80097-5
- T.G. Wells, I.R. Hendry and G.L. Kearns, Measurement of bumetanide in plasma and urine by high-performance liquid chromatography and application to bumetanide disposition, ibid, 570, 235-242 (1991) https://doi.org/10.1016/0378-4347(91)80222-X
- A.A. Halazo, W.A. Colburn, J.H. Gustafson, R.L. Young, and M. Parsonnet, Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects, J. Pharm. Sci., 73, 1108-1113 (1984) https://doi.org/10.1002/jps.2600730821
- W.R. Dixon, R.L. Young, A. Halazo, M.L. Jack, R.E. Weinfeld, K. Alexander, A. Liebman and S.A Kaplan, Bumetanide: radioimmunoassay and pharmacokinetic profile in humans, ibid, 65, 701- 704 (1976) https://doi.org/10.1002/jps.2600650518
- A.S. Singh, C. McArdle, B. Gordon, M. Ashraf and K. Granley, Simultaneous analysis of furosemide and bumetanide in horse plasma using high performance liquid chromatography, Biomed. Chromatogr., 3, 262-265 (1989) https://doi.org/10.1002/bmc.1130030607
- 식품의약품안전청 고시 제 2002-60호, 생물학적동등성 시험기준 (2002. 11. 22)